The description of the study as "double-blind" seems misleading. The two mobile apps were clearly different in nature, with the intervention mobile app having far more components than the control mobile app. It would seem that participants could clearly determine which arm they were in if one was described as informational and the other as motivational and supportive in the consent form. However, it is not clear from the write up whether individual smokers were provided any sort of informed consent that described the study arms prior to completing the baseline survey and entering the study.
There are a number of aspects of the sample that suggest the recruitment through the Apple App Store may have created a selection bias that reduced generalizability. Notably, the sample had more females, higher education, middle income, and non-married status. The sample is also limited to smokers in four highlydeveloped, Westernized countries. This probably does reflect the population of smartphone users who use mobile apps but it may not generalize to the entire population of adult smokers. This should be noted in the Discussion.
Most importantly, the smokers were predominately young (average age of 28) and half were light smokers (i.e., had low nicotine dependence). Younger smokers often do not use smoking cessation services, which may explain why a sizable number chose to quit unassisted by anything beyond the mobile app. Perhaps a decision aid such as the one used in this trial is one way to get younger smokers to try some help to quit. It would be useful to analyze whether the success of the mobile app was moderated by nicotine dependency in this trial.
The authors should briefly describe the nature of the promotional screens on the Apple App Store that advertised the mobile app to know what might have attracted smokers to download and use the mobile app.
The authors should describe how their measure of continuous smoking abstinence compares to other measures in the published literature. They also should reference and consider the arguments for and against biochemical verification of smoking abstinence selfreport (see, e.g., the Society for Research on Nicotine and Tobacco's report in 2002) when discussing this as a limitation in the Discussion.
In the description of the statistical analysis, the authors should note whether the p-value was 2-tailed or 1-tailed (page 8, line 43) and justify not using bootstrapping techniques in the mediational analysis (page 9, line 18).
The Results section could be streamlined by not repeating the numbers in text that are displayed in the tables. Also, the individual Risk Ratios should not be reported by country since the interaction between the experimental condition and country was non-significant. It is misleading to say that the mobile app was effective in three but not four countries when this interaction is non-significant.
The Discussion section needs to be extensively revised to focus on explaining, not simply repeating, the findings and drawing implications of the findings for current literature and future studies.
It would be especially useful for the authors to provide some reasons for why their mobile app worked so well in comparison to other mobile smoking cessation interventions. Also, the authors claim that their trial is the first to examine a smartphone mobile app, yet at least one of the pilot studies they cite on page 5, line 17 involved a smartphone mobile app as well as SMS text messaging (i.e., Buller, Borland, Bettinghaus et al., 2014) . The authors should focus just on explaining findings reported in the Results section and not provide additional results in the Discussion section, for example on page 12, lines 34-36 and lines 51-53 and page 13, lines 5-11. Put all findings in the Results section. The authors also should consider why using the quit benefit tracker predicted more quitting.
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GENERAL COMMENTS
This paper and the trial it reports on are excellent and I have nothing but positive things to say about the work. The paper as a whole is concise and well-written, covering all key points. The use of a real-world setting in a randomised controlled trial design is highly commendable -this is the sort of work that needs to be done more in the mHealth space. They also achieved quite a good response rate considering the hands-off approach used. 4. P10 the paragraph is confusing. It starts with "in all countries, abstinence rates at one month were higher" although it is not significant for Singapore. And the second sentence mix the comparison between countries and the fact that the increase in abstinence rate is not significant.
REVIEWER

5.
A part from the wide coverage of the population with smartphone, is there some justifications for choosing USA, UK, Australia, and Singapore for the trial?
6. In addition, do those countries have similar smoking ban policies? Could that explain the absence of difference in the abstinence rate between the intervention and control group in Singapore?
Minor comments
One limit of the smartphone smoking cessation tool is that it targets a specific population who own an expensive device and, as highlighted by the other were likely to be more motivated than the general population of smokers. It might be important to highlight that SSC won't replace the need for more smoking cessation programs, especially in low income countries.
An interesting perspective could be to propose a smartwatch application (like for physical activity) and assess whether it improve the effects of the intervention app. Comment: This study of a smartphone application with decision aids for smokers to help them quit has a number of strengths that makes it potentially an important contribution to the literature. Chief among the strengths is the size and scope (smokers from four countries) of the sample, high rate of follow-up, intent-to-treat analyses with imputation, and size of the improvement in continuous abstinence. However, the paper has several weaknesses that must be addressed before it is suitable for publication in BMJ Open.
VERSION 1 -AUTHOR RESPONSE
Authors' Response: Thank you! Comment: A large shortcoming is the lack of sufficient detail in the description of the intervention mobile app. It is alternatively described as providing a decision aid and support for smoking cessation. It seems that the former is more accurate. The features of the mobile app do not conform to common protocols for brief smoking cessation counseling and it appears that smokers were free to select any method to help them quit once they had set a quit date. This make the mobile app tested in this study different from other smoking cessation services provided by mobile phones and telephone quit lines. This should be clearly noted in the paper.
Authors' Response: We have added additional information about the intervention app on p8. Details of the app function were published in the study protocol.
Comment: In addition, the authors fail to describe any theoretical model that guided the design of the mobile app in the intervention arm. The authors do imply that making an informed decision to quit and reducing decisional conflict are precursors to quitting successfully and these precursors were targeted by the mobile app. However, there is no explanation given for these key conceptual mediators of quitting nor any description of how the mobile app components were designed to influence them. Moreover, it would be useful for the authors to conduct a mediational analysis on these two variables, not use of the mobile app features.
Authors' Response: The decision aid app design was based on the Ottawa Decision Support Framework (ODSF). This framework is the most widely used for the development of patient decision aids and it uses concepts and theories from general psychology (Tversky and Kahneman, 1981), decisional conflict (Janis and Mann, 1977) , values (Fischoff, Slovic and Lichtenstein), social support (Norbeck, 1988; Orem, 1995) , and self efficacy (Bandura, 1982) . We have added a statement to the manuscript on page 8 to clarify this. We do not feel that a meditational analysis of informed choice and decisional conflict is required in our RCT design and analysis. Our decision aid design use of the ODSF and outcome measure of the Multi-dimensional Measure of Informed Choice (MMIC) are consistent with numerous studies in this field as seen in the recently updated Cochrane review of 105 RCTs of patient decision aids. One of our investigators (Professor Trevena) is a co-author on that review.
Comment: The description of the study as "double-blind" seems misleading. The two mobile apps were clearly different in nature, with the intervention mobile app having far more components than the control mobile app. It would seem that participants could clearly determine which arm they were in if one was described as informational and the other as motivational and supportive in the consent form. However, it is not clear from the write up whether individual smokers were provided any sort of informed consent that described the study arms prior to completing the baseline survey and entering the study.
Authors' Response: As stated earlier, we have included additional details about the consent process that clarify the double-blinding aspect of our study design.
Comment: There are a number of aspects of the sample that suggest the recruitment through the Apple App Store may have created a selection bias that reduced generalizability. Notably, the sample had more females, higher education, middle income, and non-married status. The sample is also limited to smokers in four highly-developed, Westernized countries. This probably does reflect the population of smartphone users who use mobile apps but it may not generalize to the entire population of adult smokers. This should be noted in the Discussion.
Authors' Response: We have included an additional sentence to the Discussion section (p14) about generalizability beyond these four country settings.
Comment: Most importantly, the smokers were predominately young (average age of 28) and half were light smokers (i.e., had low nicotine dependence). Younger smokers often do not use smoking cessation services, which may explain why a sizable number chose to quit unassisted by anything beyond the mobile app. Perhaps a decision aid such as the one used in this trial is one way to get younger smokers to try some help to quit. It would be useful to analyze whether the success of the mobile app was moderated by nicotine dependency in this trial.
